Table of Content




1. Introduction


2. Executive Summary


3. Market Dynamics

3.1 Growth Driver
3.2 Challenges


4. United States Drugs Market

4.1 Branded Drugs Market
4.2 Generics Drugs Market


5. United States Generic Drugs Saving


6. Market Share – United States Drugs Analysis

6.1 Branded vs. Generics Drugs
6.2 Branded Generic vs. Unbranded Generic Drug
6.3 Volume Penetration – Generic vs. Branded Drugs
6.4 Therapeutic Application


7. United States Generic Drugs Market

7.1 Branded Generic Drugs Market
7.2 Unbranded Generic Drugs Market


8. Therapeutic Application – United States Generic Drugs Market

8.1 Central Nervous System (CNS)
8.2 Cardiovascular
8.3 Dermatology
8.4 Genitourinary / Hormonal Drugs
8.5 Respiratory
8.6 Anti-infective
8.7 Oncology
8.8 Others


9. Company Analysis

9.1 Teva Pharmaceutical Industries Ltd

9.1.1 Overview
9.1.2 Product Launch
9.1.3 Financial Insight

9.2 Mylan N.V.

9.2.1 Overview
9.2.2 Product Launch
9.2.3 Financial Insight

9.3 Sandoz Inc.

9.3.1 Overview
9.3.2 Product Launch
9.3.3 Financial Insight

9.4 Endo Pharmaceuticals

9.4.1 Overview
9.4.2 Product Launch
9.4.3 Financial Insight

9.5 Lupin Limited

9.5.1 Overview
9.5.2 Product Launch
9.5.3 Financial Insight

9.6 Dr Reddy’s

9.6.1 Overview
9.6.2 Product Launch
9.6.3 Financial Insight

9.7 Sun Pharmaceutical Industries Ltd.

9.7.1 Overview
9.7.2 Product Launch
9.7.3 Financial Insight



List of Figures



Figure 3-1: United States – Rising Geriatric Population (Million), 2000, 2016 & 2060
Figure 4-1: US – Pharma Market (Billion US$), 2015 – 2020
Figure 4-2: US – Forecast for Pharma Market (Billion US$), 2021 – 2026
Figure 4-3: US– Branded Pharma Market (Billion US$), 2015 – 2020
Figure 4-4: US – Forecast for Branded Pharma Market (Billion US$), 2021 – 2026
Figure 4-5: US– Generics Pharma Market (Billion US$), 2015 – 2020
Figure 4-6: US – Forecast for Generics Pharma Market (Billion US$), 2021 – 2026
Figure 5-1: Top 10 Generic Drugs Ranked by Savings in US – 2016
Figure 5-2: Ten Major US State Generic Saving in – 2016
Figure 5-3: Savings from Generics in (Billions US$), – 2016
Figure 5-4: US – Generic Drugs Saving (Billion US$), 2015 – 2020
Figure 5-5: US – Forecast for GenericDrugs Saving (Billion US$), 2021 – 2026
Figure 6-1: Branded VS Generic Drug Market Share (%), 2015 – 2020
Figure 6-2: Forecast for – Branded VS Generic Drug Market Share (%), 2021 – 2026
Figure 6-3: Branded Generic vs. Unbranded Market Share (%), 2015 – 2020
Figure 6-4: Forecast for – Branded Generic vs. Unbranded Market Share (%), 2021 – 2026
Figure 6-5: Generic V.S. Branded Drug Volume Penetration (%), 2015 – 2020
Figure 6-6: Forecast for – Generic V.S. Branded Drug Volume Penetration (%), 2021 – 2026
Figure 7-1: Branded – Generic Drug Market (Billion US$), 2015 – 2020
Figure 7-2: Branded – Forecast for Generic Drug Market (Billion US$), 2021 – 2026
Figure 7-3: Unbranded – Generic Drug Market (Billion US$), 2015 – 2020
Figure 7-4: Unbranded – Forecast for Generic Drug Market (Billion US$), 2021 – 2026
Figure 8-1: Central Nervous System Market (Billion US$), 2015 – 2020
Figure 8-2: Forecast for – Central Nervous System Market (Billion US$), 2021 – 2026
Figure 8-3: U.S Incidence of cardiovascular disease by age and sex – 2013
Figure 8-4: Cardiovascular Market (Billion US$), 2015 – 2020
Figure 8-5: Forecast for Cardiovascular Market (Billion US$), 2021 – 2026
Figure 8-6: Skin Diseases Prevalence in US – 2013
Figure 8-7: Dermatology Market (Million US$), 2015 – 2020
Figure 8-8: Forecast for – Dermatology Market (Million US$), 2021 – 2026
Figure 8-9: Genitourinary/Hormonal Drugs Market (Billion US$), 2015 – 2020
Figure 8-10: Forecast for – Genitourinary/Hormonal Drugs Market (Billion US$), 2021 – 2026
Figure 8-11: Respiratory Market (Billion US$), 2015 – 2020
Figure 8-12: Forecast for – Respiratory Market (Billion US$), 2021 – 2026
Figure 8-13: Anti – infective Market (Billion US$), 2015 – 2020
Figure 8-14: Forecast for Anti – infective Market (Billion US$), 2021 – 2026
Figure 8-15: Oncology Market (Billion US$), 2015 – 2020
Figure 8-16: Forecast for – Oncology Market (Billion US$), 2021 – 2026
Figure 8-17: Others Market (Billion US$), 2015 – 2020
Figure 8-18: Forecast for – Others Market (Billion US$), 2021 – 2026
Figure 9-1: Teva – US Generic Drugs Market (Million US$), 2015 – 2020
Figure 9-2: Teva – Forecast for US Generic Drugs Market (Million US$), 2020 – 2026
Figure 10-1: Mylan NV – US Generic Drugs Market (Million US$), 2015 – 2020
Figure 10-2: Mylan NV – Forecast for Mylan NV US Generic Drugs Market (Million US$), 2021 – 2026
Figure 11-1: Sandoz – US Generic Drugs Market (Million US$), 2015 – 2020
Figure 11-2: Sandoz – Forecast for Sandoz US Generic Drugs Market (Million US$), 2021 – 2026
Figure 12-1: Endo Pharmaceuticals – US Generic Drugs Market (Million US$), 2015 – 2020
Figure 12-2: Endo Pharmaceuticals – Forecast for US Generic Drugs Market (Million US$), 2021 – 2026
Figure 13-1: Lupin Limited – US Generic Drugs Market (Million US$), 2015 – 2020
Figure 13-2: Lupin Limited – Forecast for US Generic Drugs Market (Million US$), 2021 – 2026
Figure 14-1: Dr Reddy’s – North America (US & Canada) Generic Drugs Market (Million US$), 2015 – 2020
Figure 14-2: Dr Reddy’s – Forecast for North America (US & Canada) Generic Drugs Market (Million US$), 2021 – 2026
Figure 15-1: Sun Pharma – US Generic Drugs Market (Million US$), 2015 – 2020
Figure 15-2: Sun Pharma – Forecast for US Generic Drugs Market (Million US$), 2021 – 2026
Figure 16-1: Others – US Generic Drugs Market (Million US$), 2015 – 2020
Figure 16-2: Others – Forecast for US Generic Drugs Market (Million US$), 2021 – 2026


List of Tables


Table 6-1: US Generic Drugs – Therapeutic Application Market Share (%), 2015 – 2020
Table 6-2: US Generic Drugs – Forecast for Therapeutic Application Market Share (%), 2021 – 2026
Table 8-1: The Full Burden of 24 Skin Disease categories